The Association of Parametrial Invasion with the Expression of Vascular Endothelial Growth Factor-C and Other Factors in Squamous Cell Cervical Carcinoma Stage IB and IIA
Abstract
BACKGROUND: The presence of parametrial invasion in early stage squamous cell cervical cancer (SCCC) indeed indicates worse prognosis and need more adjuvant treatment. This study aimed to investigate the association between parametrial invasion and clinicohystopathology variables.
METHODS: This retrospective study used specimens of squamous cell carcinoma stage IB-IIA. The inclusion criteria were cervical cancer stage IB-IIA and post radical hysterectomy with lymph node dissection and exclusion criteria was damaged and or insufficient histological preparations. The clinicohystopathology variables included age, tumour size and stage, differentiation and inflammation grade, lymphatic vascular and parametrial invasion, and lymph node metastasis. Histopathology staining, immunohistochemistry examination, and vascular endothelial growth factor-C (VEGF-C) expression were evaluated according to the standard procedure. The independent-T, Chi square, and Fisher’s exact test were applied to evaluate the association. The significance was set at p<0.05.
RESULTS: Seventy-five cases were eligible. Parametrial invasion was found in 15 cases (20%). Three variables demonstrated a significant association with parametrial invasion, tumor size >4 cm (OR 4.32, 95% CI 1.29-14.38, p=0.01), lymphatic node metastasis (OR 3.90, 95% CI 1.17-13.03, p=0.02), and VEGF-C (OR 0.75, 95% CI 0.65- 0.87, p=0.03).
CONCLUSION: Tumor size of >4 cm and lymph node metastasis (LNM) had a higher risk of parametrial invasion in SCCC stage IB-IIA.
KEYWORDS: cervical carcinoma, parametrial invasion, vascular invasion, peritumoral stroma, VEGF-C expression
Full Text:
PDFReferences
Horton R. GBD 2010: understanding disease, injury, and risk. Lancet. 2012; 380: 2053-4, CrossRef.
Viens LJ, Henley SJ, Watson M, Markowitz LE, Thomas CC, Thompson TD, et al. Human papillomavirus–associated cancers—United States, 2008–2012. MMWR Morb Mortal Wkly Rep. 2016; 65: 661-6, CrossRef.
Chen Z, Huang K, Lu Z, Deng S, Xiong J, Huang J, et al. Risk model in stage IB1-IIB cervical cancer with positive node after radical hysterectomy. Onco Targets Ther. 2016; 9: 3171-9, CrossRef.
Wright JD, Grigsby PW, Brooks R, Powell MA, Gibb RK, Gao F, et al. Utility of parametrectomy for early stage cervical cancer treated with radical hysterectomy. Cancer. 2007; 110: 1281-6, PMID.
Kitadai Y, Amioka T, Haruma K, Tanaka S, Yoshihara M, Sumii K, et al. Clinicopathological significance of vascular endothelial growth factor (VEGF)-C in human esophageal squamous cell carcinomas. Int J Cancer. 2001; 93: 662-6, CrossRef.
Hadler-Olsen E, Wetting HL, Rikardsen O, Steigen SE, Kanapathippillai P, Grénman R, et al. Stromal impact on tumor growth and lymphangiogenesis in human carcinoma xenografts. Virchow Arch. 2010; 457: 677-92, CrossRef.
He Y, Rajantie I, Pajusola K, , Jeltsch M, Holopainen T, Yla-Herttuala S, et al. Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial fortumor cells entry and spread via lymphatic vessels. Cancer Res. 2005; 65: 4739-46, CrossRef.
Lohela M, Bry M, Tammela T, Alitalo K. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr Opin Cell Biol. 2009; 21: 154-65, CrossRef.
Zhang Z, Luo G, Tang H, Cheng C, Wang P. Prognostic significance of high VEGF-C expression for patients with breast cancer: An update meta analysis. PLoSONE. 2016: 11: e0165725, CrossRef.
Liu P, Chen W, Zhu H, Liu B, Song S, Shen W, et al. Expression of VEGF-C correlates with a poor prognosis based on analysis of prognostic factors in 73 patients with esophageal squamous cell carcinomas. Jpn J Clin Oncol. 2009; 39: 644-50, CrossRef.
Franc M, Kachel-Flis A, Michalski B, Fila-Daniłow A, Mazurek U, Michalski M, et al. Lymphangiogenesis in cervical cancer evaluated by expression of the VEGF-C gene in clinical stage IB-IIIB. Prz Menopauzalmy. 2015; 14: 112-7, CrossRef.
Lee K, Park DJ, Choe G, Kim HH, Kim WH, Lee HS. Increased intratumoral lymphatic vessel density correlates with lymph node metastasis in early gastric carcinoma. Ann Surg Oncol. 2010; 17: 73-80, CrossRef.
Gao P, Zhou GY, Zhang QH, Xiang L, Zhang SL, Li C, et al. Clinicopathological significance of peritumoral lymphatic vessel density in gastric carcinoma. Cancer Lett. 2008; 263: 223-30, CrossRef.
Gombos Z, Xu X, Chu CS, Zhang PJ, Acs G. Peritumoral lymphatic vessel density and vascular endothelial growth factor-c expression in early-stage squamous cell carcinoma of the uterine cervix. Clin Cancer Res. 2005; 11: 8364-71, CrossRef.
Donizy P, Rudno-Rudzinska J, Halon A, Dziegala M, Kabarowski J, Frejlich E, et al. Intratumoral but not peritumoral Lymphatic Vessel Density measured by D2-40 expression predicts poor outcome in gastric cancer – ROC curve analysis to find cut-off point. Anticancer Research. 2014; 34: 3113-8, PMID.
Stegeman M, Louwen M, van der Velden J, ten Kate FJW, den Bakker MA, Burger CW, et al. The incidence of parametrial tumor involvement in select patients with early cervix cancer is too low to justify parametrectomy. Gynecol Oncol. 2007: 105; 475-80, CrossRef.
Lee SH, Cho KJ, Ko MH, Cho HY, Lee KB, Lim S. Factors associated with parametrial involvement in patients with stage IB1 cervical cancer: Who is suitable for less radical surgery? Obstet Gynecol Sci. 2018; 61: 88-94, CrossRef.
Kim MK, Kim JW, Kim MA, Kim HS, Chung HH, Park NH, et al. Feasibility of less radical surgery for superficially invasive carcinoma of the cervix. Gynecol Oncol. 2010; 119: 187-191, CrossRef.
Frumovitz M, Sun CC, Schmeler KM, Deavers MT, dos Reis R, Levenback CF, et al. Parametrial involvement in radical hysterectomy specimens for women with early-stage cervical cancer. Obstet Gynecol. 2009; 114: 93-9, CrossRef.
Kamimori T, Sakamoto K, Fujiwara K, Umayahara K, Sugiyama Y, Utsugi K, et al. Parametrial involvement in FIGO stage IB1 cervical carcinoma diagnostic impact of tumor diameter in preoperative magnetic resonance imaging. Int J Gynecol Cancer. 2011; 21: 349-54, CrossRef.
Smith AL, Frumovitz M, Schmeler KM, dos Reis R, Nick AM, Coleman RL, et al. Conservative surgery in early-stage cervical cancer: what percentage of patients may be eligible for conization and lymphadenectomy? Gynecol Oncol. 2010; 119: 183-6, CrossRef.
Saharinen I, Tammela T, Karkkainen M, Alitalo K. Lymphatic vasculature: development, molecular regulation, and role in tumor metastasis and inflammation. Trends Immunol. 2004; 25: 387-95, CrossRef.
Botting SK, Fouad H, Elwell K, Rampy BA, Salama SA, Freeman DH, et al. Prognostic significance of peritumoral lymphatic vessel density and vascular endothelial growth factor receptor 3 in invasive squamous cell cervical cancer. Translational Oncology. 2010; 3: 170-5, CrossRef.
El-Gohary YM, Metwally G, Saad RS, Robinson MJ, Mesko T, Poppiti RJ. Prognostic significance of intratumoral and peritumoral lymphatic density and blood vessel density in invasive breast carcinomas. Am J Clin Pathol. 2008; 129: 578-86, CrossRef.
Wang XL, Fang JP, Tang RY, Chen XM. Different significance between intratumoral and peritumoral lymphatic vessel density in gastric cancer: a retrospective study of 123 cases. BMC Cancer. 2010; 10: 299, CrossRef.
Schoppmann SF, Birner P, Studer P, Breiteneder-Geleff S. Lymphatic microvessel density and lymphovascular invasion assessed by antipodoplanin immunostaining in human breast cancer. Anticancer Res. 2001; 21: 2351-5, PMID.
et al A, Matsumoto T, Kimura M, Sonoue H, Kinoshita K. Grading system of lymphatic invasion according to D2-40 immunostaining is useful for the prediction of nodal metastasis in squamous cell carcinoma of the uterine cervix. Hystopathology. 2006; 49: 493-7, CrossRef.
Gao Y, Liu Z, Gao F, Meng XY. High density of peritumoral lymphatic vessels is a potential prognostic marker of endometrial carcinoma: a clinical immunohistochemical method study. BMC Cancer. 2010; 10: 131, CrossRef.
Zhang S, Zhang D, Yi S, Gong M, Lu C, Cai Y, et al. The relationship of lympatic vessel density, lymphovascular invasion, and lymph node metastasis in breast cancer: a systematic review and metaanalysis. Oncotarget. 2017; 8: 2863-73, CrossRef.
Zhang S, Yi S, Zhang D, Gong M, Cai Y, Zou L. Intratumoral and peritumoral lymphatic vessel density both correlate with lymph node metastasis in breast cancer. Sci Rep. 2017; 7: 40364, CrossRef.
Ji RC. Lymphatic endothelial cells, tumor lymphangiogenesis, and metastasis: new insight into intratumoral and peritumoral lymphatics. Cancer Metastasis Rev. 2006; 25: 677-94, CrossRef.
Leu AJ, Berk DA, Lymboussaki A, Alitalo K, Jain RK. Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. Cancer Res. 2000; 60: 4324-7, PMID.
He KW, Sun JJ, Liu ZB, Zhuo PY, Ma QH, Liu ZY, et al. Prognostic significance of lymphatic vessel invasion diagnosed by D2-40 in Chinese invasive breast cancers. Medicine (Baltimore). 2017; 96: e8490, CrossRef.
Norhisham NF, Chong CY, Safuan S. Peritumoral lymphatic vessel density and invasion detected with immunohistochemical marker D240 is strongly associated with distant metastasis in breast carcinoma. BMC Clin Pathol. 2017; 17: 2, CrossRef.
DOI: https://doi.org/10.18585/inabj.v11i3.838
Copyright (c) 2019 The Prodia Education and Research Institute
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Indexed by:
The Prodia Education and Research Institute
